MPS Pharmaa (BOM:531686) DeferredTaxAndRevenue: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531686 MPS Pharmaa Ltd BOM:531686
25 GF Score
Price ₹2.08
! 3 Warning Signs
View Full Analysis

What is MPS Pharmaa DeferredTaxAndRevenue?

MPS Pharmaa BOM:531686 +4.52% 25 DeferredTaxAndRevenue is ₹0.00 Mil as of Jun. 2026. GuruFocus rates BOM:531686 with a GF Score™ of 25/100. The stock has 3 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

MPS Pharmaa's current deferred tax and revenue for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

MPS Pharmaa DeferredTaxAndRevenue Related Terms

MPS Pharmaa DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for MPS Pharmaa's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPS Pharmaa DeferredTaxAndRevenue Chart

MPS Pharmaa Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MPS Pharmaa Quarterly Data
Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:531686
25GF Score
MPS Pharmaa Ltd BOM:531686
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₹0.00 Mil mean?
MPS Pharmaa (BOM:531686) has a DeferredTaxAndRevenue of ₹0.00 Mil as of Jun. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on MPS Pharmaa.
Is MPS Pharmaa's DeferredTaxAndRevenue too high?
MPS Pharmaa's current DeferredTaxAndRevenue is ₹0.00 Mil. Overall, MPS Pharmaa has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does MPS Pharmaa's DeferredTaxAndRevenue compare to ZTS?
MPS Pharmaa's DeferredTaxAndRevenue of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on MPS Pharmaa. MPS Pharmaa's current DeferredTaxAndRevenue is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPS Pharmaa stock overvalued right now?
MPS Pharmaa (BOM:531686) has a current DeferredTaxAndRevenue of ₹0.00 Mil. The current DeferredTaxAndRevenue is ₹0.00 Mil. MPS Pharmaa's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For MPS Pharmaa (BOM:531686), the current DeferredTaxAndRevenue is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPS Pharmaa Business Description

Address 19 Barakhamba Road, Connaught Place, 703, Arunachal Building, New Delhi, IND, 110001
MPS Pharmaa Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing, marketing, trading, and exporting Pharmaceutical Products. The company manufactures and exports medicines that include antihypertensive medicines, antihypertensive tablets, antifungal tablets, antifungal capsules, erectile dysfunction drugs, sedatives, corticosteroid medicines, antimalarials, anthelmintics, antipyretic & anti-inflammatory, and antibacterials & antibiotics. Its products include Wibatol, Robial, Twosum, Arfa Gel, and others.
25GF Score

Get the complete analysis for BOM:531686

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2.08
Price